Human anaplasmosis presenting as atypical pneumonitis in France

Clinical Infectious Diseases

Volumn 37, Issue 6, 2003, Pages 846-848

  Remy, V ^a   Hansmann, Y ^a   De Martino, S ^b   Christmann, D ^a   Brouqui, P ^c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFPODOXIME; SPIRAMYCIN;

ADULT; ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ARTICLE; BLOOD SMEAR; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFECT; ENDEMIC DISEASE; EUROPE; FEVER; FRANCE; GIEMSA STAIN; HEADACHE; HUMAN; HYPERPLASIA; IXODES; MALE; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; SWEATING; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TICK; TREATMENT OUTCOME; UNITED STATES;

ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; FRANCE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PNEUMONIA; TICK-BORNE DISEASES;

EID: 0141717983     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377502     Document Type: Article

References (19)

1. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32:589-95.
2. Dumler JS, Barbet AF, Bekker CP, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001; 51:2145-65.
3. Blanco JR, Oteo JA. Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002; 8:763-72.
4. Parola P, Beati L, Cambon M, Brouqui P, Raoult D. Ehrlichial DNA amplified from Ixodes ricinus (Acari: Ixodidae) in France. J Med Entomol 1998; 35:180-3.
5. Schouls LM, Van DP, I, Rijpkema SG, Schot CS. Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinus ticks. J Clin Microbiol 1999; 37:2215-22.
6. Petrovec M, Lotric FS, Zupanc TA, et al. Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997; 35:1556-9.
7. Raoult D, Aboudharam G, Crubezy E, Larrouy G, Ludes B, Drancourt M. Molecular identification by "suicide PCR" of Yersinia pestis as the agent of medieval black death. Proc Natl Acad Sci U S A 2000; 97:12800-3.
8. Lin Q, Zhi N, Ohashi N, et al. Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol 2002; 40:2981-8.
9. van Dobbenburgh A, van Dam AP, Fikrig E. Human granulocytic ehrlichiosis in western Europe [letter]. N Engl J Med 1999; 340:1214-6.
10. Karlsson U, Bjoersdorff A, Massung RF, Christensson B. Human granulocytic ehrlichiosis - a clinical case in Scandinavia. Scand J Infect Dis 2001; 33:73-4.
11. Arnez M, Petrovec M, Lotric-Furlan S, Zupanc TA, Strle F. First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001; 39:4591-2.
12. Laferl H, Hogrefe W, Kock T, Pichler H. A further case of acute human granulocytic ehrlichiosis in Slovenia. Eur J Clin Microbiol Infect Dis 1999; 18:385-6.
13. Lotric-Furlan S, Petrovec M, Zupanc TA, et al. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin Infect Dis 1998; 27:424-8.
14. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000; 31:554-60.
15. Case records of the Massachusetts General Hospital. Weekly clinico-pathological exercises. Case 37-2001: a 76-year-old man with fever, dyspnea, pulmonary infiltrates, pleural effusions, and confusion. N Engl J Med 2001; 345:1627-34.
16. Lepidi H, Bunnell JE, Martin ME, Madigan JE, Stuen S, Dumler JS. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg 2000; 62:29-37.
17. Lotric-Furlan S, Avsic-Zupanc T, Petrovec M, et al. Clinical and serological follow-up of patients with human granulocytic ehrlichiosis in Slovenia. Clin Diagn Lab Immunol 2001; 8:899-903.
18. Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME, et al. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob Agents Chemother 2001; 45:786-8.
19. Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997; 41:76-9.